Researchers Repurpose Cancer-Fueling Protein Into Tumor-Fighting Weapon
Researchers have identified a counterintuitive strategy for cancer treatment: turning a protein that typically fuels tumor growth into a tool for destroying cancer cells.
The protein, called PPARD, plays a dual role in cancer progression. While it can promote cancer growth in certain contexts, scientists discovered that activating PPARD specifically in immune cells transforms them into more effective tumor hunters. These modified immune cells showed improved fat-burning capacity and enhanced ability to attack and destroy cancer cells.
Laboratory experiments demonstrated the approach's effectiveness across multiple cancer types, including colorectal, breast, and ovarian cancers, as well as melanoma. In these tests, the activated immune cells were able to slow or halt tumor growth.
The findings suggest a potential new avenue for cancer immunotherapy, though researchers note that further studies will be needed to determine whether this approach could be translated into clinical treatments for human patients.